UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
INTELLIA THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 36-4785571 | |
(State of incorporation or organization) | (I.R.S. Employer Identification No.) | |
130 Brookline Street, Suite 201 Cambridge, Massachusetts |
02139 | |
(Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
|
Common Stock, $0.0001 par value per share | The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨
Securities Act registration statement file number to which this form relates:
333-210689
Securities to be registered pursuant to Section 12(g) of the Act:
None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. | Description of Registrants Securities to be Registered. |
For a description of the Registrants common stock, $0.0001 par value per share, to be registered hereunder, reference is made to the information set forth under the heading DESCRIPTION OF CAPITAL STOCK Common Stock in the Registrants prospectus that constitutes a part of the Registrants Registration Statement on Form S-1, as amended (File No. 333-210689) (the Registration Statement), filed with the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the Securities Act), which information is hereby incorporated by reference. Any form of the prospectus subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act that constitutes part of the Registration Statement shall be deemed to be incorporated herein by reference.
Item 2. | Exhibits. |
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement on Form 8-A to be signed on its behalf by the undersigned, thereto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on the 5th day of May, 2016.
INTELLIA THERAPEUTICS, INC. | ||
By: | /s/ Nessan Bermingham | |
Nessan Bermingham, Ph.D. Founder, President and Chief Executive Officer |